<DOC>
	<DOCNO>NCT00739674</DOCNO>
	<brief_summary>To evaluate effectiveness diet management losartan base titration regimen versus losartan base titration regimen alone blood pressure reduction hypertensive patient .</brief_summary>
	<brief_title>SAALT : Subtracting Salt Adding Losartan Trial ( 0954A-335 )</brief_title>
	<detailed_description />
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>Non Diabetic , Newly Diagnosed And Untreated For Mild To Moderate Hypertension ( blood pressure &gt; 161 ; &lt; 221 ; 140/90 mm Hg But &lt; 180/110 mm Hg ) Non diabetic , newly diagnose untreated severe hypertension ( blood pressure &gt; 180/110 mm Hg &lt; 200/120 mm Hg ) ; Patients asymptomatic evidence significant end organ damage include direct pressure effect include . Patients urgency/emergency state exclude Or Diabetic , Newly Diagnosed With Hypertension And Untreated With Mild To Moderate Hypertension ( blood pressure &gt; 161 ; &lt; 221 ; 130/80 mm Hg But &lt; 160/100 mm Hg ) ; Or Patient Receiving One Antihypertensive Agent ( Monotherapy Only ) Used To Treat Hypertension For At Least 4 Weeks And Whose Blood Pressure Is Not Controlled : blood pressure &gt; 161 ; &lt; 221 ; 140/90 mm Hg But &lt; 160/100 mm Hg Or For Diabetic And/Or Coronary Artery Disease Patients : blood pressure &gt; 161 ; &lt; 221 ; 130/80 mm Hg But &gt; 161 ; &lt; 221 ; 150/90 mm Hg The Antihypertensive Agent Will Need To Be Discontinued Prior To Starting Study Drug Known Secondary Hypertension Of Any Aetiology ( E.G. , Uncorrected Renal Artery Stenosis , Malignant Hypertension , Hypertensive Encephalopathy . Patient With Symptomatic Heart Failure ( Classes 3 And 4 ) . Patient With A Prior Myocardial Infarction Or Stroke Within The Last 6 Months Patient Has Undergone Percutaneous Coronary Angioplasty , Has Had Coronary Artery Bypass Within The Last 6 Months Or Has Unstable Angina Patient With Anuria Or Confirmed Clinically Significant Renal Or Hepatic Dysfunction ( Taken From Current/Past Medical Records ) And/Or Electrolyte Imbalance Laboratory Test Within The Last 3 Months Prior To Visit 1 : Serum Creatinine &gt; 130 ÃŒmol/L Or Creatinine Clearance &lt; 45 Ml/Min , Ast &gt; 3 Times Above The Normal Range , Alt &gt; 3 Times Above The Normal Range , Serum Potassium &lt; 3.5 Or &gt; 5.5 Meq/L Significant Liver Or Respiratory Disease , Cancer Or Other concomitant Disease That Is Likely To Affect Life Expectancy Of The Patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>